Public trial registry of the CCC-Munich

Trial AIO KRK 0306 / FIRE-3

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
AIO KRK 0306 / FIRE-3
World
Full title
:

Randomisierte Studie zur Wirksamkeit von FOLFIRI in Kombination mit Cetuximab vs. Bevacizumab in der Erstlinien-Behandlung des metastasierten kolorektalen Karzinoms

World
EudraCT number
:
World
NCT number
:
World
Responsible organization
:
Medizinische Klinik III, Telefon: 089440072551
Indications
Classification Code Description
ICD-10-GM C19 Bösartige Neubildung am Rektosigmoid, Übergang
- Gastrointestinal tumors
- Colorectal carcinoma
Trial design
World
Trial type
:
Interventional
World
Blinding type
:
Open
World
Phase
:
III
Status
World
Status
:
Recruitment finished
Votes
World
Institutional review board - vote
:
Unknown
Initiiation & lock
World
Date of lock (planned / actual)
:
2016-12-31 / 2012-10-01
Therapy
World
Therapy line
:
1
Participants
Function Prename Surname Organization
World Principal Investigator VOLKER HEINEMANN Keine Organisationseinheit angegeben Magnifier